• 58

    Illustration by Leandro Castelao

    SOURCE

    November 2016

    Drug testing could get a lot cheaper with chips designed to mimic the human body.

    Earlier this year, French company Biotrial held a clinical trial to test a new anti-anxiety drug. It didn’t go well: Five of the eight participants became ill, and one died. Disasters like this are rare. But also rare are clinical trials that go well: Ninety percent of drugs tested on humans do not work. These failures are an expensive but necessary part of the estimated $2.6 billion it costs to bring a medicine to market.

    A lab in California is working on a more efficient and humane process, based on a quarter-size plastic slide. It’s a tiny replica of the human brain, rendered in clusters of about 300,000 cells surrounded by small copper wires. Based on that, Lawrence Livermore ­National Lab (LLNL) researchers have set out to build a comprehensive human body in miniature. Called the iChip, it could be the future of drug testing.

    “Most people aren’t really thrilled with us injecting anything new into a human,” says Heather Enright, an iChip researcher. But testing drugs on animals instead provides limited information. For example, tumors develop differently in mice than they do in humans. With iChip, a dose of a new medication could be injected into the cells of a mini organ, and researchers could monitor the effects without harming live subjects.

    In addition to the brain, and a peripheral nervous system (think spinal cord), the LLNL scientists have created a rudimentary heart and a tangle of 3D-printed blood vessels, which they plan to use to link organs together. The end product won’t look like tiny human innards, but the network of cells, vessels, and neurons will carry out the same functions. Right now, the biggest challenge is “getting the cells to be happy on the device,” says Elizabeth Wheeler, the project’s principal investigator. Cells are picky, and can die in response to subtle changes in acidity or humidity. That’s why it was notable when, in July, the team announced that they kept a section of a human nervous system ­functioning for a record 23 full days.

    Harvard, MIT, and Los Alamos National Lab (LANL) are building tiny organs of their own, which could one day link up with iChip. Beyond testing drugs, organs on chips could be made with a specific patient’s cells to find the best treatment for that person. “Everybody responds to drugs a little differently,” says Jennifer Harris, a researcher at LANL. Such personalized regimes could be the future of medicine.

    This article was originally published in the November/December 2016 issue of Popular Science, under the title “Human-Free Human Trials.”

     
     

    No comments

    Be the first one to leave a comment.

    Post a Comment


     

     

    Latest Posts

    Latest Video

     
     

    LATEST POSTS

    Self-assembling 3D printing inks produce more true-to-life tissue

    SOURCE Biological and chemical researchers are developing 3D printable inks capable of self-assembly, i.e. forming a shape based on a…

    Urine Exosomes – An Emerging Trove of Biomarkers

     SOURCE Exosomes are released by most cells and can be isolated from all biofluids including urine. Exosomes are small vesicles…

    What is machine learning?

    SOURCE In this fascinating animation from Oxford Sparks, we take a look at how statistics and computer science can be used to…

    Catalia Health uses social robots to improve health outcomes

    Credit: Catalia Health SOURCE Catalia Health is leading the surge in social robotics, with Mabu, their patient care management system. Catalia…

    Ambry Genetics’ Big Data Sharing Program Now Available for Public Download

    SOURCE (So, WHY is this important?  Sounds like good Hangout fodder for the person that wants to know!) January 19,…

    Big data serves patients and people in increasingly broad ways

    Personal Connected Health Alliance executive vice president Patty Mechael explains how genomics, fitness devices and other wearables are engaging people…

    The Long Quest To Create Artificial Blood May Soon Be Over

    A drop of blood drips off a needle. Image Source via Getty Images SOURCE Blood, blood everywhere — but not…

    ‘5-D protein fingerprinting’ with nanopores could give insights into Alzheimer’s, Parkinson’s

    SOURCE Jan 17, 2017 (Nanowerk News) In research that could one day lead to advances against neurodegenerative diseases like Alzheimer’s…